Latest Regulatory Milestones News

Vysarn Limited is set to transform its water services platform with the $60 million acquisition of Welltech, funded by a fully underwritten $65.3 million placement. The deal promises over 37% EPS accretion on a pro forma FY26 basis.

Clinuvel Pharmaceuticals targets year-end for topline results from its pivotal vitiligo trial of SCENESSE® combined with narrowband UVB, aiming to expand the drug's use beyond its current rare disease indication.

Desane Group Holdings progresses key developments in Penrith and Leichhardt, with construction milestones and tenant arrangements set to boost recurring income.

Lumos Diagnostics reported a 6% revenue increase to US$13.2 million for FY26, driven by an 875% surge in FebriDx® sales following a pivotal CLIA waiver. The company expanded U.S. adoption to 170+ healthcare sites and secured milestone payments exceeding US$6 million.

Echo IQ has locked in a strategic $20 million investment and US partnership with Pro Medicus, alongside a $110 million capital raise, positioning the company for accelerated commercial expansion of its AI-driven cardiovascular diagnostics in the US.

Syntara secured positive FDA feedback for its Phase 2b amsulostat trial in myelofibrosis and raised $8 million to extend its cash runway to Q3 2027, while preliminary data showed promising brain inflammation reduction in a Parkinson’s-related disorder.

BlinkLab has bolstered its war chest with a A$17.5 million placement, secured a foundational US patent valid through 2041, and made significant progress in its FDA autism diagnostic trial and European ADHD study.

Stanmore Resources bounced back from early-year weather disruptions with a 27% jump in ROM coal production in Q2 2026 and secured a refinancing deal that lowers debt costs and extends maturities, positioning the company for a robust second half.

Resouro Strategic Metals has taken a crucial step toward turning its Novo Mundo Gold Project in Brazil from trial mining into a licensed commercial operation by lodging a Mining Concession Application covering 930 hectares.

Zeotech completed a 110-hole drilling campaign at Toondoon, secured key approvals, progressed AusPozz™ commercial trials, and demonstrated a 92% methane reduction in landfill trials.

Argenica Therapeutics is gearing up for a pivotal late-stage clinical trial of its neuroprotective drug ARG-007 (xaranetide) in acute ischaemic stroke, backed by strong safety assays and solid funding.

Li-S Energy marked key commercial and regulatory milestones in Q2 2026, including ISO 9001:2015 certification for its lithium foil line, first commercial foil sale, and US air transport approvals for lithium-sulfur cells. The company also completed a major Battery Testing Centre expansion and began deep-ocean cell testing with MSubs.